… have been identified in several human cancers including specific breast cancer … of circulating
miRNAs as potential diagnostic and prognostic biomarkers as well as therapeutic targets …

… of miRNAs as potential biomarkers in cancer: in particular, circulating miRNAs can be released
from the tumor … : Luminal A, Luminal B, HER2 positive, TN (triple negative, or basal-like), …

… , and may be potential biomarkers for detecting cancer. They are … , which could be therapeutic
targets, are also recommended. … based on carboplatin is higher than that in HER2-positive …

… diagnostic/prognostic biomarkers and therapeutic target molecules, apart from a better
understanding of tumor growth processes. In the current study, we identified miRNA signatures in …

… are readily accessible non-invasive potential biomarkers for TNBC … Circulating miRNAs
have been shown to have potential as biomarkers and therapeutic targets in both HER2-positive …

… , potential therapeutic targets, or therapeutic tools in breast … on early changes of circulating
miRNA levels from T0 to T1 [65]. … Given these data, ser-miR-21 could be a potential biomarker …

… explored as potential therapeutic targets for management of cancer patients, … circulating
miRNAs identified in BC patients as potential diagnostic, prognostic, and predictive biomarkers, …

… 3. Discussion The value of circulating miRNAs as potential biomarkers for cancer patient
management is not a novelty [17]. Nevertheless, data are few and conflicting in BC due to …

… , making them potential biomarkers for early diagnosis, prognosis, or predicting … Herein, we
will review the potential predictive value of circulating miRNAs regarding treatment response …

… We further discuss associated therapeutic targets if … HER2-positive BC represents 15% of
all BCs in which gene … have identified MALAT1 as a potential biomarker in TNBC, helping to …